The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

NHS criteria and how they are applied in practice

This is a generated summary. It shows the 6 most-liked posts from a topic of 43, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
UC
unit_conversionTL3Regular12 Jun 2026#2

Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.

26 likes 1mo
MN
ma.nascimentoTL2 Moderator23 Jun 2026 · edited#9

Coming back to post #7, because the follow-up matters more than the original answer.

Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed.

27 likes 1mo
N
NardoneTL2Member25 Jun 2026#11

Picking up post #8: that is the part I would want checked first.

MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria and costs.

32 likes 1mo
SC
sourced_claimsTL3Regular11 Jul 2026#26

Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That is not a front-line option but becomes relevant during shortages.

33 likes 17d
KR
k.roosTL2 Moderator22 Jul 2026#38

Regional variation in NHS: access varies dramatically by region depending on local commissioning decisions and specialist service availability. Postcode determines access risk.

26 likes 6d
IB
i.boatengTL2 Moderator25 Jul 2026#42

Occupational health screening: some UK occupations require medical checks. Disclosure of weight-loss medication might be relevant to employment screening; understand your obligations.

27 likes 2d

Read the full topic (43 posts)

Promoted into the documentation commons. The content of this topic is maintained at Access notes: Ireland, with named maintainers and a review date. The promotion was discussed in doc review. Corrections are best raised against the document, which is the version that gets kept current.

Suggested topics

TopicParticipantsRepliesViewsActivity
Second pass at: Pharmacy supply in the UK and the questions you will be asked
Second pass at: Pharmacy supply in the UK and the questions you will be asked Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail…
DBDATFHKD+46 53 14k 12mo
About the UK & Ireland category
MHRA positions, NHS pathways, private prescriptions, and Irish differences. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and a…
SLHSJVIAK+3 7 357 3mo
UK access routes, dated and sourced
UK access routes, dated and sourced Writing it up because I had to work it out twice and would rather nobody else did. Documenting an access outcome, dated, because everything in this category expires. As of…
NROJC 2 5.8k 15mo
Pharmacy supply in the UK and the questions you will be asked
On the subject in the title: Pharmacy supply in the UK and the questions you will be asked Working notes rather than a conclusion. A coverage question with the paperwork detail included, since that is what…
CMCBRMNSP+95 105 1.3k 4mo
MHRA statements, read directly — the long version
On the subject in the title: MHRA statements, read directly — the long version Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires. As of…
BRTDSL 2 44k 22mo

Related topics — sharing the tags NHS, cost per milligram, personal import

TopicParticipantsRepliesViewsActivity
EU-wide position versus national implementation
EU-wide position versus national implementation Writing it up because I had to work it out twice and would rather nobody else did. Documenting an access outcome, dated, because everything in this category…
BBCLSGLEVK+22 29 356 11mo
Revisiting: Language barriers in accessing a prescription abroad
Posting this under the heading it deserves: Revisiting: Language barriers in accessing a prescription abroad Everything below is what sits behind that. Documenting an access outcome, dated, because everything…
MMLSSLMIMH+131 148 28k 5mo
Personal import allowances, compared
On the subject in the title: Personal import allowances, compared Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires. As of July 2026, in…
BANNKAKSC+5 9 3.2k 7mo
Travelling with an injectable: documentation and practicalities
Posting this under the heading it deserves: Travelling with an injectable: documentation and practicalities Everything below is what sits behind that. Documenting an access outcome, dated, because everything…
CHATJSFEB+37 42 2.1k 1d
Price changes over 2025 and 2026, tabulated and dated — does this still hold?
Price changes over 2025 and 2026, tabulated and dated — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Documenting an access outcome, dated,…
WMCCDFKSDO+147 156 18k 3mo